alexa Actinic keratosis | Ireland | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Actinic Keratosis

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Actinic keratosis

    An actinic keratosis is a rough, scaly patch on your skin that develops from years of exposure to the sun. It's most commonly found on your face, lips, ears, back of your hands, forearms, scalp or neck. Also known as solar keratosis, an actinic keratosis enlarges slowly and usually causes no signs or symptoms other than a patch or small spot on your skin. 

  • Actinic keratosis

    Over time, actinic keratoses may develop into invasive squamous cell carcinoma; according to one study of almost 7000 patients, among the small percentage of actinic keratoses that progress into squamous cell carcinoma, the length of time for this transformation to occur was approximately 2 years.Cells within actinic keratoses (AKs) show characteristic UV-induced gene mutations.

  • Actinic keratosis

    Studies in the Ireland indicate that 19–24% of people over 60 years of age have AKHowever, 15–25% of these lesions will spontaneously regress within 12 months, and less than 1 in 1000 progress to become invasive squamous cell carcinoma (SCC). Where there is concern over the possibility of this, the patient should be referred using the 2-week wait mechanism.

  • Actinic keratosis

    Emollient (strength of recommendation A, quality of evidence, I) Where emollient has been used in the placebo limb of randomised control trials, it has resulted in improvement in over 40% of subjects;sun-damaged skin is often dry and emollient will address this aspect of the problem. 5% 5-fluorouracil cream (A, I) Application twice daily for 3 weeks reduces lesions to about 25% of their number or surface involvement.

 

High Impact List of Articles

Conference Proceedings